Varicella seroprevalence in Turkish population in Cyprus

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 6, 2007, Pages 861-863

  Kurugol, Zafer ^a,b   Koturoglu, Guldane ^a   Aksit, Sadik ^a   Ozacar, Tijen ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Seroprevalence; Vaccination; Varicella

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHICKENPOX; CHILD; CYPRUS; DEMOGRAPHY; ENZYME ASSAY; FAMILY SIZE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; TURKEY (REPUBLIC); VARICELLA ZOSTER VIRUS; VIRUS DETECTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; CHICKENPOX; CHILD; CHILD, PRESCHOOL; CYPRUS; FAMILY; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 34249813138     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00289.x     Document Type: Article

References (23)

1. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992 11 : 441 5.
2. Gershon AA, Takahashi M, Seward J. Varicella vaccine. In : Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia : Saunders, 2004 : 783 823.
3. White CJ. Varicella-virus virus vaccine. Clin Infect Dis 1997 24 : 753 63.
4. Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995 95 : 791 6.
5. Rentier B, Gershon AA. Members of the European Working Group on Varicella (EuroVar). Consensus: varicella vaccination of healthy children. Pediatr Infect Dis J 2004 23 : 379 89.
6. Pinot de Mora A, Nardone A. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Eurosurveillance 2005 10 : 3 4.
7. Aebi C, Fischer K, Gorgievski M, Matter L, Mühlemann K. Age specific seroprevalence to varicella zoster virus: study in Swiss children and analysis of European data. Vaccine 2001 19 : 3097 103.
8. Rothenberg RB, Labanov A, Singh KB, Stroh Jr. G. Observations on the application of EPI cluster survey methods for estimating disease incidence. Bull World Health Organ 1985 63 : 93 9.
9. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 1982 60 : 253 60.
10. Wharton M. The epidemiology of varicella-zoster virus infection. Infect Dis Clin North Am 1996 10 : 571 81.
11. Lolekha S, Tantthiphabha W, Sornchai P, da Cunha S, Costa D, Corte-Real R, et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 2001 64 : 131 6.
12. Salleras L, Dominguez A, Vidal J, Plans P, Salleras M, Taberner JL. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 2000 19 : 183 8.
13. Khoshnood B, Debruyne M, Lancon F, Emery C, Fagnani F, Durand I, et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 2006 25 : 41 4.
14. Oliveira J, Dias N, Ferreira TM, Kosuwan P, Sutra S, Warachit B, et al. The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas. Acta Med Port 1999 12 : 155 60.
15. Cohen DI, Davidovici BB, Smetana Z, Balicer RD, Klement E, Mendelson E, et al. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines. Infection 2006 34 : 208 13.
16. Kanra G, Tezcan S, Badur S, Turkish National Study Team. Varicella seroprevalence in a random sample of the Turkish population. Vaccine 2002 20 : 1425 8.
17. Alp H, Altinkaynak S, Ertekin V, Kilicaralan B, Giraksin A. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey. Health Policy 2005 72 : 119 24.
18. Musharrafieh UM, Nuwayhid IA, Hamadeh GN, Steitieh SW, Bizri AR. Immunity to chickenpox among school adolescents in Lebanon and options for vaccination. Epidemiol Infect 2002 129 : 607 15.
19. Gabutti G, Penna C, Rossi M, Salmaso S, Rota M, Bella A, et al. The seroepidemiology of varicella in Italy. Epidemiol Infect 2001 126 : 433 40.
20. Kavaliotis J, Petridou S, Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis 2003 7 : 274 7.
21. Echevarria JM, Ory F, Leon P, Tellez A. Definition of high-proficiency serological markers for diagnosis of varicella-zoster virus infections by immunoassay. J Med Virol 1989 27 : 224 30.
22. Heininger U, Braun-Fahrlander C, Desgrandchamps D. Seroprevalence of varicella zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J 2001 20 : 775 8.
23. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001 20 : 121 4.